Abstract
Atrial fibrillation (AF) and heart failure (HF) are two pathological conditions that frequently coexist.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW (1998) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction. J Am Coll Cardiol 32:695–703
Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 155:469–473
Ryder KM, Benjamin EJ (1999) Epidemiology and significance of atrial fibrillation. Am J Cardiol 84:131 R-138R
Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306:1018–1022
Middlekauff HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84:4048
Jung F, Di Marco JP (1998) Treatment strategies for atrial fibrillation. Am J Med 104:272–286
Wellens HJ, Lau CP, Luderitz B et al (1998) Atrioverter: an implantable device for treatment of atrial fibrillation. Circulation 98:1651–1656
Daoud EG, Timmermanns C, Fellows C et al (2000) Initial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Metrix investigators. Circulation 102:1407–1413
Timmermanns C, Levy S, Ayers G et al (2000) Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: observations on treated and non-treated episodes. Metrix investigators. J Am Coll Cardiol 35:1428–1433
Schmitt C, Montero M, Melichercik J (1998) Significance of supraventricular tachyarrhhythmias in patients with implanted pacing cardioverter defibrillators. Pacing Clin Electrophysiol 17:295–302
Best PJ, Hayes DL, Stanton MS (1999) The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 22:79–85
Grimm W, Flores B, Marchlinski FE (1995) Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 6:832–851
Swerdlow C, Schoels W, Dijkman B et al (2000) Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. Circulation 101:878–885
Schoels W, Swerdlow DC, Jung W et al (2001) Worldwide clinical experince with a new dual-chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 12:521–528
Adler SW II, Wolpert C, Warman EN et al (2001) Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 104:887–892
Friedman PA, Dijkman B, Warman EN, et (2001) Atrial therapies reduce atrial arrhythmia burden in defibrillator patients.Circulation 104:1023–1028
Gold MR, Sulke N, Schwartzman DS et al (2001) Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 12:1247–1253
Lopez Gil M, Arribas F, Cosio FG (2000) Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy. Europace 2:327–332
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Italia
About this paper
Cite this paper
Dini, P., Laurenzi, F. (2003). Drugs and Implantable Cardioverter Defibrillators in Patients with Atrial Fibrillation and Heart Failure. In: Gulizia, M. (eds) New Advances in Heart Failure and Atrial Fibrillation. Springer, Milano. https://doi.org/10.1007/978-88-470-2087-0_11
Download citation
DOI: https://doi.org/10.1007/978-88-470-2087-0_11
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2169-3
Online ISBN: 978-88-470-2087-0
eBook Packages: Springer Book Archive